Literature DB >> 23890154

Melanomas of unknown primary have a mutation profile consistent with cutaneous sun-exposed melanoma.

Ken Dutton-Regester1, Hojabr Kakavand, Lauren G Aoude, Mitchell S Stark, Michael G Gartside, Peter Johansson, Linda O'Connor, Cathy Lanagan, Varsha Tembe, Gulietta M Pupo, Lauren E Haydu, Christopher W Schmidt, Graham J Mann, John F Thompson, Richard A Scolyer, Nicholas K Hayward.   

Abstract

Melanoma of unknown primary (MUP) is an uncommon phenomenon whereby patients present with metastatic disease without an evident primary site. To determine their likely site of origin, we combined exome sequencing from 33 MUPs to assess the total rate of somatic mutations and degree of UV mutagenesis. An independent cohort of 91 archival MUPs was also screened for 46 hot spot mutations highly prevalent in melanoma including BRAF, NRAS, KIT, GNAQ, and GNA11. Results showed that the majority of MUPs exhibited high somatic mutation rates, high ratios of C>T/G>A transitions, and a high rate of BRAF (45 of 101, 45%) and NRAS (32 of 101, 32%) mutations, collectively indicating a mutation profile consistent with cutaneous sun-exposed melanomas. These data suggest that a significant proportion of MUPs arise from regressed or unrecognized primary cutaneous melanomas or arise de novo in lymph nodes from nevus cells that have migrated from the skin.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  melanoma of unknown primary; mutation profile; sequencing

Mesh:

Year:  2013        PMID: 23890154     DOI: 10.1111/pcmr.12153

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN: 1755-1471            Impact factor:   4.693


  18 in total

1.  Unexpected UVR and non-UVR mutation burden in some acral and cutaneous melanomas.

Authors:  Robert V Rawson; Peter A Johansson; Nicholas K Hayward; Nicola Waddell; Ann-Marie Patch; Serigne Lo; John V Pearson; John F Thompson; Graham J Mann; Richard A Scolyer; James S Wilmott
Journal:  Lab Invest       Date:  2017-01-09       Impact factor: 5.662

2.  Prevalence of NRAS Mutation, PD-L1 Expression and Amplification, and Overall Survival Analysis in 36 Primary Vaginal Melanomas.

Authors:  Hai-Yun Wang; Xiao-Yan Wu; Xiao Zhang; Xin-Hua Yang; Ya-Kang Long; Yan-Fen Feng; Fang Wang
Journal:  Oncologist       Date:  2019-10-02

3.  Multidisciplinary Care for Melanoma of Unknown Primary: Experience in the Era of Molecular Profiling.

Authors:  James P De Andrade; Paul Wong; Michael P O'Leary; Vishwas Parekh; Arya Amini; Hans F Schoellhammer; Kim A Margolin; Michelle Afkhami; Laleh G Melstrom
Journal:  Ann Surg Oncol       Date:  2020-09-09       Impact factor: 5.344

4.  Whole-genome landscapes of major melanoma subtypes.

Authors:  Nicholas K Hayward; James S Wilmott; Nicola Waddell; Peter A Johansson; Matthew A Field; Katia Nones; Ann-Marie Patch; Hojabr Kakavand; Ludmil B Alexandrov; Hazel Burke; Valerie Jakrot; Stephen Kazakoff; Oliver Holmes; Conrad Leonard; Radhakrishnan Sabarinathan; Loris Mularoni; Scott Wood; Qinying Xu; Nick Waddell; Varsha Tembe; Gulietta M Pupo; Ricardo De Paoli-Iseppi; Ricardo E Vilain; Ping Shang; Loretta M S Lau; Rebecca A Dagg; Sarah-Jane Schramm; Antonia Pritchard; Ken Dutton-Regester; Felicity Newell; Anna Fitzgerald; Catherine A Shang; Sean M Grimmond; Hilda A Pickett; Jean Y Yang; Jonathan R Stretch; Andreas Behren; Richard F Kefford; Peter Hersey; Georgina V Long; Jonathan Cebon; Mark Shackleton; Andrew J Spillane; Robyn P M Saw; Núria López-Bigas; John V Pearson; John F Thompson; Richard A Scolyer; Graham J Mann
Journal:  Nature       Date:  2017-05-03       Impact factor: 49.962

Review 5.  Treatment Outcomes for Metastatic Melanoma of Unknown Primary in the New Era: A Single-Institution Study and Review of the Literature.

Authors:  Kierstin Utter; Chloe Goldman; Sarah A Weiss; Richard L Shapiro; Russell S Berman; Melissa Ann Wilson; Anna C Pavlick; Iman Osman
Journal:  Oncology       Date:  2017-07-27       Impact factor: 2.935

Review 6.  From melanocytes to melanomas.

Authors:  A Hunter Shain; Boris C Bastian
Journal:  Nat Rev Cancer       Date:  2016-04-29       Impact factor: 60.716

Review 7.  Sun exposure, sunbeds and sunscreens and melanoma. What are the controversies?

Authors:  Veronique Bataille
Journal:  Curr Oncol Rep       Date:  2013-12       Impact factor: 5.075

8.  The combination of stereotactic radiosurgery with immune checkpoint inhibition or targeted therapy in melanoma patients with brain metastases: a retrospective study.

Authors:  Filipe Martins; Luis Schiappacasse; Marc Levivier; Constantin Tuleasca; Michel A Cuendet; Veronica Aedo-Lopez; Bianca Gautron Moura; Krisztian Homicsko; Adrienne Bettini; Gregoire Berthod; Camille L Gérard; Alexandre Wicky; Jean Bourhis; Olivier Michielin
Journal:  J Neurooncol       Date:  2019-12-14       Impact factor: 4.130

9.  Improved survival of patients with melanoma brain metastases in the era of targeted BRAF and immune checkpoint therapies.

Authors:  Sarah Sloot; Yian A Chen; Xiuhua Zhao; Jamie L Weber; Jacob J Benedict; James J Mulé; Keiran S Smalley; Jeffrey S Weber; Jonathan S Zager; Peter A Forsyth; Vernon K Sondak; Geoffrey T Gibney
Journal:  Cancer       Date:  2017-10-12       Impact factor: 6.860

10.  Mechanisms of base substitution mutagenesis in cancer genomes.

Authors:  Albino Bacolla; David N Cooper; Karen M Vasquez
Journal:  Genes (Basel)       Date:  2014-03-05       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.